ORBIMED ADVISORS LLC

Q4 2020 13F-HR Detailed Holdings

Location
New York, NY
Holdings as of
12/31/2020
Date filed
2/16/2021
Form type
13F-HR
Num holdings
149
Total value ($000)
$11,428,040
Net value change ($000)
+3,471,857 (43.6%)
New positions
26
Sold out positions
19
Turnover %
16.4%
Sector allocation + QoQ delta (equities-only)

Holdings broken out by other managers reported in the original SEC filing. View aggregated holdings

You are on the SEC detailed breakdown page. Rows are shown as reported in the filing (including other manager, discretion, and voting authority fields), and are not merged like the standard holdings view. Switch to aggregated holdings.

Snapshot: Change Analysis

Compared to Q3 2020
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
PRLD 645,939 137.5%
SPRY 405,053 NEW
ABCL 338,047 NEW
PMVP 190,664 73.3%
SpringWorks Therapeutics, Inc. 184,046 52.1%
Prevail Therapeutics Inc. 178,171 126.6%
Kinnate Biopharma Inc. 153,071 NEW
UNH 136,870 NEW
PFE 133,127 NEW
ELV 99,698 NEW
Top Reduces (Value $000, Stocks/ETFs)
ALXN -223,567 -89.4%
BIIB -73,458 -36.2%
XLRN -67,638 -100.0%
EXEL -58,780 -100.0%
ASND -57,227 -50.5%
ELDN -54,435 -100.0%
NVO -22,912 -100.0%
BNR -22,897 -19.2%
Tricida, Inc. -19,324 -22.2%
IVERIC bio, Inc. -19,243 -100.0%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 9,754 (0.1% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type Discretion Other Manager Sole Shared None

Other Managers

Num Name File Number
1 ORBIMED CAPITAL LLC 028-10410